Concomitant use of LUMIGAN and antiglaucomatous agents other than topical
in Off topic
Wed Nov 08, 2017 7:00 am
• 990 Posts
No interactions are anticipated in humans, since systemic concentrations of bimatoprost are extremely low (less than 0.2 ng/ml) following ocular dosing with bimatoprost 0.3 mg/ml eye drops, solution. Bimatoprost is biotransformed by any of multiple enzymes and pathways, and no effects on hepatic drug metabolising enzymes were observed in preclinical studies.
In clinical studies, bimatoprost 0.3 mg/ml, eye drops, solution was used concomitantly with a number of different ophthalmic beta-blocking agents without evidence of interactions.
Concomitant use of LUMIGAN and antiglaucomatous agents other than topical beta-blockers has not been evaluated during adjunctive glaucoma therapy.After learning about the lash growth phase, we can choose the proper product to change it.lumigan bimatoprost ophthalmic solution is used to nourish lash follicle during the Anagen phase and increase lash size.By using this wonder lash growth serum, you can regrow naturally longer lash in 4-8 weeks without any side effect.lumigan is one of the most cost-effective eyelash serums in the market, it contains FDA approved bimatoprost to nourish and enhance lash size.Just feel free to take a try.
There is a potential for the IOP-lowering effect of prostaglandin analogues (e.g. LUMIGAN) to be reduced in patients with glaucoma or ocular hypertension when used with other prostaglandin analogues (